You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

I-125 seeds implantation

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Brachytherapy, NSCLC Trial in Beijing (3D-printing Template-assisted CT-guided I-125 Seeds Implantation)

Recruiting
  • Brachytherapy
  • Non-small Cell Lung Cancer
  • 3D-printing Template-assisted CT-guided I-125 Seeds Implantation
  • Beijing, Beijing, China
    Peking University Third Hospital
May 31, 2022

Hepatocellular Carcinoma, Hepatic Portal Vein Tumor Invasion, Tumor Thrombus Trial (I-125 Seeds Brachytherapy in PVTT,

Not yet recruiting
  • Hepatocellular Carcinoma
  • +2 more
  • I-125 Seeds Brachytherapy in PVTT
  • +2 more
  • (no location specified)
Aug 14, 2023

3D-PCT Combined With CT-guided Radioactive I-125 Seed

Recruiting
  • Malignant Tumor of Head and/or Neck
  • Radioactive Iodine-125 Seeds Implantation
  • Beijing, China
    Department of Radiation Oncology of Peking university third hosp
Jul 18, 2022

3D-PT Assisted CT-guided I-125 Seeds Implantation for Recurrent

Recruiting
  • Recurrent Rectal Cancer
  • +2 more
  • CTV
  • Beijing, Beijing, China
    Peking Unnversity Third Hospital
Jan 13, 2021

Metastatic Pancreatic Cancer Trial in Shanghai (Iodine125-Seeds implantation, Gem/nab-P Chemotherapy)

Not yet recruiting
  • Metastatic Pancreatic Cancer
  • Iodine125-Seeds implantation
  • Gem/nab-P Chemotherapy
  • Shanghai, Shanghai, China
    Changhai Hospital
May 11, 2023

Hepatocellular Carcinoma, Portal Vein Occlusion, Tumor Thrombus Trial in Guangzhou (TACE combined with iodine-125 seeds

Active, not recruiting
  • Hepatocellular Carcinoma
  • +2 more
  • TACE combined with iodine-125 seeds implantation
  • TACE
  • Guangzhou, Guangdong, China
    The 2nd Affiliated Hospital of Guangzhou Medical University
Mar 2, 2022

Recurrent Chest Wall Malignancies After EBRT

Recruiting
  • Chest Wall Tumor
  • Radioactive Iodine-125 Seeds Implantation
  • Beijing, Beijing, China
    Peking University Third Hospital
May 31, 2022

Sarcoma,Soft Tissue, Brachytherapy, Poly(ADP-ribose) Polymerase Inhibitors Trial in Guangzhou (Fluzoparib, Radioactive particle

Recruiting
  • Sarcoma,Soft Tissue
  • +2 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
May 30, 2023

Hepatocellular Carcinoma Non-resectable Trial in Guangzhou (TACE combined with sorafenib/lenvatinib and iodion-125 seeds

Recruiting
  • Hepatocellular Carcinoma Non-resectable
  • TACE combined with sorafenib/lenvatinib and iodion-125 seeds brachytherapy
  • TACE combined with sorafenib/lenvatinib
  • Guangzhou, Guangdong, China
    the Second Affiliated Hospital of Guangzhou Medical University
Jul 27, 2021

Hilar Cholangiocarcinoma Trial in Xuzhou (I-125 seeds loaded stent (self-expanded metal stent with I-125 seeds, Micro-Tech,

Enrolling by invitation
  • Hilar Cholangiocarcinoma
  • I-125 seeds loaded stent (self-expanded metal stent with I-125 seeds, Micro-Tech, Nanjing, China)
  • Normal stent (self-expanded metal stent without I-125 seeds, Micro-Tech, Nanjing, China)
  • Xuzhou, Jiangsu, China
    Xuzhou Central Hospital
Jul 12, 2021

Radioactive Iodine-125 Brachytherapy, Thoracic Cancer, 3D Printing Coplanar Template Trial in Beijing (Radioactive seed

Recruiting
  • Radioactive Iodine-125 Brachytherapy
  • +3 more
  • Radioactive seed brachytherapy
  • Beijing, Beijing, China
    Peking University Third Hospital
May 31, 2022

CT-guided Radioactive I-125 Seeds Implantation for Early Stage

Completed
  • Early Stage Non-small Cell Lung Cancer
  • CT-guided Radioactive I-125 Seeds Implantation
  • (no location specified)
May 19, 2019

Hepatocellular Carcinoma Non-resectable Trial in Guangzhou (Lenvatinib Plus I-125 Seed Brachytherapy, Lenvatinib)

Recruiting
  • Hepatocellular Carcinoma Non-resectable
  • Guangzhou, Guangdong, China
    The Second Affiliated Hospital of Guangzhou Medical University
Nov 2, 2022

AK104 Combined With I-125 Brachytherapy for Recurrent or

Not yet recruiting
  • Cervical Cancer
  • Iodine-125 particle brachytherapy
  • AK104
  • (no location specified)
Sep 25, 2023

Prostate Cancer Trial in Kuopio (Hypofractionated RT 5 x 7,25 Gy, LDR-brachytherapy with I125 seeds)

Active, not recruiting
  • Prostate Cancer
  • Hypofractionated RT 5 x 7,25 Gy
  • LDR-brachytherapy with I125 seeds
  • Kuopio, Finland
    Kuopio University Hospital
Feb 17, 2021

Malignant Airway Obstruction Trial in Wenzhou (stent implantation)

Unknown status
  • Malignant Airway Obstruction
  • stent implantation
  • Wenzhou, Zhejiang, China
    The first affiliated hospital of wenzhou medical university
May 8, 2019

Breast Cancer Trial in Sittard (Pintuition)

Active, not recruiting
  • Breast Cancer
  • Pintuition
  • Sittard, Limburg, Netherlands
    Zuyderland Medical Center
Sep 19, 2023

Breast Tumors Trial in Toronto (Permanent breast seeds implant)

Completed
  • Breast Neoplasms
  • Permanent breast seeds implant
  • Toronto, Ontario, Canada
    Sunnybrook Odette Cancer Centre
Oct 22, 2021

Coplanar Template Assistance for Head and Neck Biopsies.

Recruiting
  • Head and Neck Neoplasms
    • Beijing, Beijing, China
      Department of Radiation Oncology of Peking university third hosp
    May 25, 2022

    Pituitary Macroadenoma Trial in Dallas (Iodine Implants)

    Terminated
    Has Results
    • Pituitary Macroadenoma
    • Iodine Implants
    • Dallas, Texas
      University of Texas Southwestern Medical Center
    Nov 29, 2021

    Prostate Cancer Trial in Kelowna (Low dose rate prostate brachytherapy, High Dose Rate prostate brachytherapy)

    Recruiting
    • Prostate Cancer
    • Low dose rate prostate brachytherapy
    • High Dose Rate prostate brachytherapy
    • Kelowna, British Columbia, Canada
      British Columbia Cancer Agency Center for the Southern Interior
    Mar 3, 2022

    Retinitis Pigmentosa Trial in Shanghai (AuTNA I)

    Recruiting
    • Retinitis Pigmentosa
    • AuTNA I
    • Shanghai, Shanghai, China
      Chunhui Jiang
    May 2, 2023

    Prostate Cancer Recurrent Trial in Toronto (HDR brachytherapy)

    Active, not recruiting
    • Prostate Cancer Recurrent
    • HDR brachytherapy
    • Toronto, Ontario, Canada
      Odette Cancer Centre, Sunnybrook Health Sciences Centre
    May 3, 2022

    Alzheimer's Disease (AD)-Related Seeds for AD Diagnosis

    Recruiting
    • Alzheimer's Disease
      • Beijing, Beijing, China
        Xuanwu Hospital of Capital Medical University
      Nov 15, 2022

      Aortic Dissection Trial (AMDS; Artivion, Atlanta, Georgia, US, Conventional hemiarch replacement)

      Not yet recruiting
      • Aortic Dissection
      • AMDS; Artivion, Atlanta, Georgia, US
      • Conventional hemiarch replacement
      • (no location specified)
      Sep 16, 2023